189 related articles for article (PubMed ID: 17570496)
1. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation.
Wang W; Bergh A; Damber JE
Prostate; 2007 Aug; 67(11):1238-46. PubMed ID: 17570496
[TBL] [Abstract][Full Text] [Related]
2. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.
Wang W; Bergh A; Damber JE
Prostate; 2009 Sep; 69(13):1378-86. PubMed ID: 19507201
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
Wang W; Bergh A; Damber JE
Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
[TBL] [Abstract][Full Text] [Related]
4. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation.
Wang W; Bergh A; Damber JE
APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591
[TBL] [Abstract][Full Text] [Related]
5. C/EBPbeta is over-expressed in gastric carcinogenesis and is associated with COX-2 expression.
Regalo G; Canedo P; Suriano G; Resende C; Campos ML; Oliveira MJ; Figueiredo C; Rodrigues-Pereira P; Blin N; Seruca R; Carneiro F; Machado JC
J Pathol; 2006 Dec; 210(4):398-404. PubMed ID: 16981245
[TBL] [Abstract][Full Text] [Related]
6. p16 Is upregulated in proliferative inflammatory atrophy of the prostate.
Faith D; Han S; Lee DK; Friedl A; Hicks JL; De Marzo AM; Jarrard DF
Prostate; 2005 Sep; 65(1):73-82. PubMed ID: 15880529
[TBL] [Abstract][Full Text] [Related]
7. An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis.
Hu B; Ullenbruch MR; Jin H; Gharaee-Kermani M; Phan SH
J Pathol; 2007 Mar; 211(4):455-62. PubMed ID: 17177178
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer.
Wang W; Bergh A; Damber JE
Clin Cancer Res; 2005 May; 11(9):3250-6. PubMed ID: 15867220
[TBL] [Abstract][Full Text] [Related]
9. The role of CCAAT/enhancer-binding protein beta in the transcriptional regulation of COX-2 in human amnion.
Lee YS; Terzidou V; Lindstrom T; Johnson M; Bennett PR
Mol Hum Reprod; 2005 Dec; 11(12):853-8. PubMed ID: 16399783
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.
König JE; Senge T; Allhoff EP; König W
Prostate; 2004 Feb; 58(2):121-9. PubMed ID: 14716737
[TBL] [Abstract][Full Text] [Related]
11. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.
Bundy LM; Sealy L
Oncogene; 2003 Feb; 22(6):869-83. PubMed ID: 12584567
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal expression of CCAAT/enhancer binding proteins alpha and beta in hepatoblastomas and its prognostic significance.
Tomizawa M; Horie H; Yamamoto H; Matsunaga T; Sasaki F; Hashizume K; Hiyama E; Kaneko M; Suita S; Ando H; Hayashi Y; Ohnuma N; Nakagawara A
Oncol Rep; 2007 Feb; 17(2):341-4. PubMed ID: 17203171
[TBL] [Abstract][Full Text] [Related]
13. CCAAT/enhancer binding protein beta mediates expression of matrix metalloproteinase 13 in human articular chondrocytes in inflammatory arthritis.
Hayashida M; Okazaki K; Fukushi J; Sakamoto A; Iwamoto Y
Arthritis Rheum; 2009 Mar; 60(3):708-16. PubMed ID: 19248099
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma suppresses cyclooxygenase-2 promoter activity by inhibiting C-Jun and C/EBPbeta binding.
Deng WG; Montero AJ; Wu KK
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1752-9. PubMed ID: 17556653
[TBL] [Abstract][Full Text] [Related]
15. Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia.
Kapadia R; Tureyen K; Bowen KK; Kalluri H; Johnson PF; Vemuganti R
J Neurochem; 2006 Sep; 98(6):1718-31. PubMed ID: 16899075
[TBL] [Abstract][Full Text] [Related]
16. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
17. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation.
Gerstenbluth RE; Seftel AD; MacLennan GT; Rao RN; Corty EW; Ferguson K; Resnick MI
J Urol; 2002 May; 167(5):2267-70. PubMed ID: 11956490
[TBL] [Abstract][Full Text] [Related]
18. Expression of C/EBPalpha and C/EBPbeta in glial cells in vitro after inducing glial activation by different stimuli.
Pérez-Capote K; Saura J; Serratosa J; Solà C
Neurosci Lett; 2006 Dec; 410(1):25-30. PubMed ID: 17070994
[TBL] [Abstract][Full Text] [Related]
19. Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer.
Gatti G; Quintar AA; Andreani V; Nicola JP; Maldonado CA; Masini-Repiso AM; Rivero VE; Maccioni M
Prostate; 2009 Sep; 69(13):1387-97. PubMed ID: 19496069
[TBL] [Abstract][Full Text] [Related]
20. Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.
Diallo JS; Aldejmah A; Mouhim AF; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
BJU Int; 2008 May; 101(10):1302-9. PubMed ID: 18294307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
